Imaging against multiple sclerosis: Iodinated radiotracer candidate for PET and SPECT imaging
Friday, February 4, 2011 - 14:00
in Mathematics & Economics
(PhysOrg.com) -- A first-line treatment for relapsing forms of multiple sclerosis (MS) was approved in September 2010 by the US Food and Drug Administration: FTY720 (fingolimod, Gilenya), which acts as a sphingosine 1-phosphate (S1P) receptor modulator.